GWM Advisors LLC reduced its holdings in shares of Clorox Co (NYSE:CLX) by 95.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,031 shares of the company’s stock after selling 61,664 shares during the period. GWM Advisors LLC’s holdings in Clorox were worth $464,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in the stock. BlackRock Inc. increased its holdings in shares of Clorox by 0.8% during the 1st quarter. BlackRock Inc. now owns 10,639,351 shares of the company’s stock worth $1,707,189,000 after buying an additional 83,514 shares during the last quarter. Northern Trust Corp boosted its position in Clorox by 3.4% in the first quarter. Northern Trust Corp now owns 2,355,067 shares of the company’s stock worth $377,894,000 after purchasing an additional 76,799 shares during the last quarter. Geode Capital Management LLC boosted its position in Clorox by 21.5% in the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock worth $292,347,000 after purchasing an additional 335,835 shares during the last quarter. Janus Henderson Group PLC boosted its position in Clorox by 1.9% in the second quarter. Janus Henderson Group PLC now owns 1,804,217 shares of the company’s stock worth $276,243,000 after purchasing an additional 33,032 shares during the last quarter. Finally, Swiss National Bank boosted its position in Clorox by 2.6% in the first quarter. Swiss National Bank now owns 912,292 shares of the company’s stock worth $146,386,000 after purchasing an additional 22,900 shares during the last quarter. 75.88% of the stock is currently owned by institutional investors.
CLX has been the topic of several research reports. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a research report on Monday, July 29th. BMO Capital Markets set a $168.00 target price on Clorox and gave the company a “buy” rating in a research report on Thursday, May 2nd. Argus downgraded Clorox from a “buy” rating to a “hold” rating in a research report on Monday, May 20th. Morgan Stanley raised their target price on Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a research report on Friday, August 2nd. Finally, Citigroup set a $156.00 target price on Clorox and gave the company a “hold” rating in a research report on Thursday, May 23rd. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $154.07.
Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The business’s quarterly revenue was down 3.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.66 EPS. As a group, analysts forecast that Clorox Co will post 6.4 earnings per share for the current year.
In other news, SVP Michael R. Costello sold 3,225 shares of Clorox stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $161.34, for a total transaction of $520,321.50. Following the sale, the senior vice president now owns 29,669 shares of the company’s stock, valued at $4,786,796.46. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $157.61, for a total value of $3,215,086.39. Following the sale, the senior vice president now directly owns 4,896 shares in the company, valued at approximately $771,658.56. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 29,011 shares of company stock worth $4,575,097. Corporate insiders own 1.40% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: What are retained earnings?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.